104 related articles for article (PubMed ID: 25916927)
1. [Application of Navosure impedance controlled endometrial ablation system in treating the intrauterine disease].
Zhu W; Mao J; Liu X
Zhonghua Yi Xue Za Zhi; 2015 Feb; 95(7):515-8. PubMed ID: 25916927
[TBL] [Abstract][Full Text] [Related]
2. Abnormal Uterine Bleeding Control by Sequential Application of Hysteroscopic Lesion Morcellation and Endometrial Ablation.
Rubino RJ; Roy KH; Presthus J; Trupin S
J Reprod Med; 2017; 62(3-4):102-10. PubMed ID: 30230300
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of endometrial ablation for treating abnormal uterine bleeding in pre- and postmenopausal women with liver cirrhosis.
Liu Q; Li XL; Liu JJ; Song XH; Jiang XY; Li W; Zhang H; Pan CQ
J Obstet Gynaecol Res; 2016 Dec; 42(12):1753-1760. PubMed ID: 27647778
[TBL] [Abstract][Full Text] [Related]
4. Endometrial Ablation in Women With Abnormal Uterine Bleeding Related to Ovulatory Dysfunction: A Cohort Study.
Hokenstad AN; El-Nashar SA; Khan Z; Hopkins MR; Famuyide AO
J Minim Invasive Gynecol; 2015; 22(7):1225-30. PubMed ID: 26149205
[TBL] [Abstract][Full Text] [Related]
5. Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial.
Athanatos D; Pados G; Venetis CA; Stamatopoulos P; Rousso D; Tsolakidis D; Stamatopoulos CP; Tarlatzis BC
Clin Exp Obstet Gynecol; 2015; 42(3):347-51. PubMed ID: 26152008
[TBL] [Abstract][Full Text] [Related]
6. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
Sabbah R; Desaulniers G
J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
[TBL] [Abstract][Full Text] [Related]
7. Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation.
Xie H; Wan Y; Yi S; Zeng F; Sun X; Yang Y; Xiao S
Int J Gynaecol Obstet; 2022 Aug; 158(2):301-307. PubMed ID: 34653258
[TBL] [Abstract][Full Text] [Related]
8. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
Glasser MH; Heinlein PK; Hung YY
J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
[TBL] [Abstract][Full Text] [Related]
9. [Clinical observation of microwave endometrial ablation for treatment of abnormal uterine bleeding].
Wang HL; Zhang X; Chen SQ; Yang YF; Sun XZ; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):445-8. PubMed ID: 16080868
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of magnetic resonance-guided focused ultrasound surgery (MRgFUS) ablation in the management of abnormal uterine bleeding due to uterine leiomyoma or adenomyosis.
Huang Y; Zhou S; Wang J; Pang Z
Am J Transl Res; 2022; 14(1):656-663. PubMed ID: 35173883
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of NovaSure
Philip CA; Le Mitouard M; Maillet L; de Saint-Hilaire P; Huissoud C; Cortet M; Dubernard G
Eur J Obstet Gynecol Reprod Biol; 2018 Aug; 227():46-51. PubMed ID: 29886317
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcomes following resectoscopic endometrial ablation of non-atypical endometrial hyperplasia in women with abnormal uterine bleeding.
Vilos GA; Oraif A; Vilos AG; Ettler H; Edris F; Abu-Rafea B
J Minim Invasive Gynecol; 2015 Jan; 22(1):66-77. PubMed ID: 25048567
[TBL] [Abstract][Full Text] [Related]
13. NovaSure impedance controlled endometrial ablation: long-term follow-up results.
Fulop T; Rákóczi I; Barna I
J Minim Invasive Gynecol; 2007; 14(1):85-90. PubMed ID: 17218236
[TBL] [Abstract][Full Text] [Related]
14. [Study on women with abnormal uterine bleeding treated by hysteroscopic electric resection].
Zhang X; Lin J; Xu K
Zhonghua Fu Chan Ke Za Zhi; 2000 Dec; 35(12):727-9. PubMed ID: 11286031
[TBL] [Abstract][Full Text] [Related]
15. [Application of TB type thermal balloon endometrial ablation for the treatment of abnormal uterine bleeding].
Wang W; Zhai Y; Zhang ZH; Li Y; Zhang ZY
Zhonghua Yi Xue Za Zhi; 2016 Nov; 96(41):3333-3336. PubMed ID: 27852381
[No Abstract] [Full Text] [Related]
16. Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study.
Scordalakes C; delRosario R; Shimer A; Stankiewicz R
Int J Womens Health; 2018; 10():137-145. PubMed ID: 29713204
[TBL] [Abstract][Full Text] [Related]
17. NovaSure impedance controlled system for endometrial ablation: the experience of the first UK reference centre.
Elmardi A; Furara S; Khan F; Hamza M
J Obstet Gynaecol; 2009 Jul; 29(5):419-22. PubMed ID: 19603322
[TBL] [Abstract][Full Text] [Related]
18. Endometrial hydrothermablation: a comparison of short-term clinical effectiveness in patients with normal endometrial cavities and those with intracavitary pathology.
Rosenbaum SP; Fried M; Munro MG
J Minim Invasive Gynecol; 2005; 12(2):144-9. PubMed ID: 15904618
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives.
Miller JD; Lenhart GM; Bonafede MM; Basinski CM; Lukes AS; Troeger KA
Int J Womens Health; 2015; 7():59-73. PubMed ID: 25610002
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the NovaSure endometrial ablation procedure in women with uterine cavity length over 10 cm.
Thiel JA; Briggs MM; Pohlman S; Rattray D
J Obstet Gynaecol Can; 2014 Jun; 36(6):491-497. PubMed ID: 24927186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
